Related by context. Frequent words. (Click for all words.) 65 IPSS 62 DAS# [002] 60 placebo p 60 annualized relapse 58 plus methotrexate 57 PANSS 57 creatinine clearance 57 ACR# [002] 56 certolizumab pegol 56 LVEF 56 belimumab 56 mg BID 56 ADHD RS 55 proteinuria 55 Secondary endpoints included 55 log# 55 A1C levels 54 HbA1c levels 54 laboratory abnormalities 54 sustained virologic response 54 serum phosphorus 54 peginterferon alfa 2a 54 placebo p = 54 copies mL 54 primary efficacy endpoint 53 % CI #.#-#.# [006] 53 fasting plasma glucose 53 g dL 53 severe renal impairment 53 IU mL 53 confidence interval #.#-#.# 53 symptom severity 53 EDSS 53 hypokalemia 52 Secondary endpoints include 52 leukopenia 52 FEV1 52 secondary endpoint 52 P = .# 52 HCV RNA 52 confidence interval CI 51 microalbuminuria 51 impaired fasting glucose 51 Arch Intern Med 51 nmol L 51 statistically significant p 51 free survival PFS 51 vertebral fracture 51 undetectable viral load 50 ≥ 50 nonsignificant 50 RECIST criteria 50 dyspnea 50 treatment emergent adverse 50 thromboembolic events 50 adalimumab 50 mg dL 50 Secondary endpoints 50 preoperatively 50 mm Hg 49 evaluable 49 diastolic pressure 49 prespecified 49 composite endpoint 49 hemoglobin A1c 49 eGFR 49 orthostatic hypotension 49 pg mL 49 mcg kg 49 glomerular filtration rate 49 renal impairment 49 fasting insulin 49 hypercalcemia 48 fasting blood glucose 48 target lesion revascularization 48 comorbidity 48 mL min 48 nonresponders 48 target vessel revascularization 48 mmol L 48 albuminuria 48 mmHg 48 HbA1c 48 limiting toxicity 48 ng mL 48 evaluable patients 48 endarterectomy 48 Fully taxable 48 cardiovascular mortality 48 depressive symptoms 48 postoperatively 48 renal dysfunction 48 acute myocardial infarction AMI 48 STELARA 48 insulin glargine 48 oral glucose tolerance 47 median PFS 47 mg dose 47 p = #.# [004] 47 p = 47 systolic pressure